Concepedia

Significance of <i>TP53</i> Mutational Status‐Associated Signature in the Progression and Prognosis of Endometrial Carcinoma

Ying Chen, Wancheng Zhao, Fangfang Bi, Xue Pan, Lili Yin, Chengzhi Zhao

Oxidative Medicine and Cellular Longevity · 2022 · 10 citations · 25 references

DOIFull text

Open access

Abstract

In summary, our research constructed a powerful TP53 mutational status-associated signature that could be a potential novel prognostic biomarker and therapeutic target for EC.

References

25

Cancer statistics, 2020

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21K citations · Full text

Integrated genomic characterization of endometrial carcinoma

Nature · 2013 · 5.6K citations · Full text

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański et al. · New England Journal of Medicine · 2018 · 3.1K citations · Full text

<i>TP53</i>Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck

Maria Luana Poeta, Judith Manola, Meredith A. Goldwasser et al. · New England Journal of Medicine · 2007 · 809 citations · Full text

A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysis

Jie Wu, Huibo Zhang, Lan Li et al. · Cancer Communications · 2020 · 563 citations · Full text